A potential window to complete the IPL is before the Twenty20 World Cup in October, when England are scheduled to tour Bangladesh and Pakistan
England's centrally contracted players are likely to miss the remainder of the Covid-19-hit Indian Premier League season if the Twenty20 tournament clashes with the international schedule, managing director Ashley Giles said on Monday.
The IPL was suspended indefinitely last week after several personnel tested positive for Covid-19. India reported 366,161 new COVID-19 infections on Monday, taking the case load to 22.66 million.
A potential window to complete the IPL is before the Twenty20 World Cup in October, when England are scheduled to tour Bangladesh and Pakistan.
"If those tours go ahead I'd expect them (players) to be there," Giles told British media. "We're planning on involvement of England players in England matches."
Giles had previously agreed that England players who were involved in the latter stages of the IPL could miss the two-test series against top-ranked New Zealand starting June 2.
"The New Zealand scenario was very different," Giles said. "Those matches were formalised at the end of January, by which time contracts were signed for players to have full involvement in the IPL."
Following the postponement of the IPL, England internationals Jos Buttler, Sam Curran, Chris Woakes, Jonny Bairstow and Moeen Ali - all currently serving their 10-day isolation period in government-approved hotels - could now be available for selection.
But Giles said those in quarantine will not be rushed back into the team and England are likely to consider a bigger pool of players this summer.
Good to see Ashley Giles standing firm over any potential clash between a rescheduled IPL and England fixtureshttps://t.co/XA52u73cqc— Mike atherton (@Athersmike) May 11, 2021
"We need to look after them, with the amount of cricket they've got coming up, we're not going to rush or force them back into cricket," Giles said.
"(Head coach) Chris Silverwood will work with each and every one of them, as will our medical teams, on what's best for their progress."